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Previous work has shown that mature B cells depend
upon survival signals delivered to the cells by their
antigen receptor (BCR). To identify the molecular
nature of this survival signal, we have developed
a genetic approach in which ablation of the BCR is
combinedwith the activation of specific, BCRdepen-
dent signaling cascades in mature B cells in vivo.
Using this system, we provide evidence that the
survival of BCR deficient mature B cells can be
rescued by a single signaling pathway downstream
of the BCR, namely PI3K signaling, with the FOXO1
transcription factor playing a central role.
INTRODUCTION
Mature B cells in the peripheral immune system depend on two
central survival determinants, the B cell antigen receptor (BCR)
and the receptor for the tumor necrosis factor (TNF) family cyto-
kine, BAFF (Lam et al., 1997; Ng et al., 2005). Whereas the BCR
controls the response of the cells to cognate antigen, the
BAFF-R senses BAFF produced by neighboring cells in the
B cell habitat and is thus critically involved in controlling B cell
numbers. In BAFF or BAFF-R deficient mice, mature B cells
scarcely develop, and BAFF depletion in adult animals leads to
rapid apoptosis of these cells (Batten et al., 2000; Thompson
et al., 2000; Yan et al., 2001). In the case of the BCR, using
systems of induced and stage-specific gene targeting, Lam
et al. (1997) and Kraus et al. (2004) demonstrated that mature
B cells undergo apoptosis upon in vivo BCR ablation or mutation
of one of its signaling units, the Iga polypeptide chain, and disap-
pear from the body with a half-life of 3-6 days. This indicated that
the BCR on resting, mature B cells transmits ‘‘tonic’’ survival
signals into the cells, either upon interaction with ligands in
the environment or spontaneously. The notion of ‘‘tonic’’ BCR
signals keeping mature B cell alive is supported by additional,
more indirect evidence (Bannish et al., 2001; Grande et al.,
2007; Stadanlick et al., 2008).Which pathways downstream of the BCR and BAFF-R signal B
cell survival? Upon BAFF engagement, the BAFF-R signals mainly
through the alternative NF-kB pathway, and there is evidence that
BAFF-R-mediated activation of the latter is critical for mature
B cell survival, although additional factors may be involved
(Mecklenbrauker et al., 2004; Sasaki et al., 2006). However, in
the case of the BCR, which can activate multiple signaling
cascades, the nature of the survival signal has remained unre-
solved. One recent hypothesis is based on evidence that BCR
engagement can activate the canonical NF-kB signaling pathway
and mature B cells require canonical NF-kB signals for their in vivo
maintenance (Cariappa et al., 2000; Pasparakis et al., 2002). This
led Stadanlick et al. (2008) to propose a model in which mature B
cell survival is based on an NF-kB-mediated crosstalk between
BCR and BAFF-R. In this model, BCR-mediated canonical NF-
kB signals enhance BAFF-R signaling by transcriptional upregula-
tion of the genes encoding BAFF-R on the one hand and p100,
a critical component of the alternative NF-kB pathway, on the
other (Bonizzi and Karin, 2004). However, while this mechanism
may well play a role upon B cell activation, its role in B cell main-
tenance remained speculative and is not easily compatible with
other experimental evidence (Ruland et al., 2001; Xue et al., 2003).
In an attempt to directly assess the molecular nature of the
BCR-mediated survival signal for mature B cells, we have devel-
oped a system, in which conditional ablation of the BCR in
mature B cells in vivo is combined with the conditional activation
of candidate signaling cascades in the same cells. Using this
approach, we find that mature B cells losing their BCR are fully
rescued by activation of the PI3K signaling pathway, but not
that of canonical NF-kB. Thus, PI3K signaling, which has
recently emerged as a critical determinant of B cell development
(Aiba et al., 2008; Deane and Fruman, 2004; Herzog et al., 2008;
Omori et al., 2006; Verkoczy et al., 2007) also provides a critical
survival signal for mature B cells.
RESULTS
Experimental Design
For targeted deletion of the BCR in mature B cells, we used the
CD21-cre transgene, expressed when B cells differentiate fromCell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc. 573
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transitional to mature cells (Kraus et al., 2004), in combination
with theB1-8f allele, in which the B1-8 VDJ gene segment, sitting
in its physiological position in the IgH locus, is flanked by loxP
sites (Lam et al., 1997). We complemented this system by a third
genetic element, which would rescue the BCR deficient cells
by concomitant, Cre-mediated activation of a survival signal
mimicking the one normally provided by the BCR. Following a
strategy which we had previously developed (Sasaki et al.,
2006), we generated a series of ROSA26 alleles harboring
cDNAs of constitutively active signaling molecules, preceded
by a loxP flanked STOP cassette and marked by a GFP gene
under the control of an internal ribosomal entry site downstream
of the inserted cDNA. In combination with CD21-cre and B1-8f,
cDNA and GFP expression would coincide with BCR deletion
in mature B cells, allowing us to determine whether a signaling
pathway is activated which rescues BCRneg mature B cells
(Figure 1A).
Constitutively Active PI3K Rescues BCR-Negative
B Cells
One of the constitutively active signaling molecules that we
conditionally expressed from the ROSA26 locus was MP110*,
a constitutively active form of P110a, the catalytic subunit of
PI3K (Klippel et al., 1996). For simplicity, we will refer to this allele,
which is described in Figure S1 (available online), as P110*
throughout the paper.
As compound mutant mice expressing P110* in mature B cells
died soon after birth, possibly due to the expression of CD21-
cre, and consequently P110*, in the forebrain (Schmidt-Supprian
and Rajewsky, 2007), we studied the requirement of PI3K activity
for the survival of BCRneg B cells in chimeric mice, generated by
transfer of fetal liver cells of the compound mutants into synge-
neic RAG2/common g chain deficient recipients, which are
lymphocyte deficient (Cao et al., 1995). Lymphocyte develop-
ment was reconstituted in the chimeric mice, and no lethality
was observed in recipients of either CD21-cre;B1-8f/JHT or
P110*/+;CD21-cre;B1-8f/JHT fetal liver cells. JHT is a null allele
of the IgH locus (Gu et al., 1993), introduced into the system to
limit IgH expression to the B1-8f allele.
In accord with our previous work (Kraus et al., 2004), IgMneg
B cells were detectable in spleens from CD21-cre; B1-8f/JHT
fetal liver chimeric mice, but did not accumulate beyond
around 10% of total mature B cells in steady state
(Figure 1B). In striking contrast, 77% of splenic mature B cells
(B220+, AA4.1-) from P110*/+; CD21-cre; B1-8f/JHT chimeras
were IgMneg. Essentially all and only those cells expressed
GFP, indicating that Cre-mediated recombination occurred at
the IgH and the ROSA26 locus with equal efficiency, andconsistent with a requirement of P110* expression for the
survival of these cells. The increased percentage of mature
(B220+, AA4.1-) B cells in the chimeras carrying the P110*
allele is consistent with the counter selection of such cells
when they loose their BCR in the absence of P110* expression
(Kraus et al., 2004).
Rescue of BCRneg mature B cells by P110* was also seen in
other lymphoid organs. Thus, a large fraction of mature (B220
high) B cells in the bone marrow of P110*/+; CD21-cre; B1-8f/
JHT chimeras were IgM
neg and expressed GFP, whereas in the
absence of the P110* allele all B220 high cells were IgMpos (Fig-
ure 1B, bottom row). Large numbers of GFP expressing IgMneg
B cells also accumulated in the peritoneal cavity and lymph
nodes of compound mutant chimeras carrying the P110* allele
(Figure 1C).
Numerically, the rescue of BCRneg mature B cells by P110* was
extremely effective.P110*/+; CD21-cre; B1-8f/JHT chimeras had
more than twice the number of splenic B cells of their P110*-
negative counterparts, with almost all of the increase being due
to the accumulation of IgMneg cells (Figure 1D). In comparison
to mice without ongoing BCR ablation in mature B cells (B1-8f/
JHT), the P110* rescue of IgMneg B cells generated a somewhat
expanded peripheral B cell compartment (Figure 1D), partly due
to a moderate expansion of the Marginal Zone (MZ) B cell subset
(Figure S2).
P110*-Rescued BCR-Negative BCells Resemble Normal
Mature B Cells
Histologically, a normal organization of BCRneg B cells into folli-
cles and adjacent MZ was seen in the spleen, with a majority of
BCRneg, B220+ cells intermingled with a minority of BCRpos,
B220+ cells that had not undergone Cre-mediated recombina-
tion (Figures 2A and 2B). When analyzed by flow cytometry,
mutant and control cells were identical in forward scatter anal-
ysis and expressed similar levels of the B cell markers B220,
CD19 and CD21 (Figure 2C). CD23 was about 2-fold downre-
gulated on the cells compared to controls, a phenomenon
that will be further discussed below. Significantly, no upregula-
tion of the activation markers CD95, CD69 and MHC II was
seen in the rescued cells, suggesting that they were in a resting
state like normal, mature B cells (Figure 3A). Accordingly, 84%
of these cells did not incorporate bromodeoxyuridine (BrdU)
into their DNA over a 20 day feeding period, similar to the
80% unlabelled cells in the controls (Figure 3B,C; Forster and
Rajewsky, 1990). In contrast, 50% of the IgMneg B cells in
compound mutants lacking the P110* allele incorporated
BrdU, indicative of their rapid turnover (Kraus et al., 2004). An
unexpected finding was the low degree of BrdU incorporationFigure 1. Constitutively Active PI3K Rescues BCR-Negative B Cells
(A) Schematic representation of the experimental strategy.
(B) Representative FACS analysis of spleen and bone marrow lymphocytes. Numbers represent percentages of cells within the lymphocyte gate or of cells in the
gate indicated in the FACS plot. Expression of P110* leads to accumulation of BCRneg mature B cells (B220+, AA4.1-) in the spleen that are GFP positive. The
histogram plot in the bone marrow section compares GFP expression in the progenitor gate (B220 low, IgMneg) and the IgMneg mature B cell gate (B220 high,
IgMneg) from P110*/+; CD21-cre; B1-8f/JHT mice.
(C) FACS analysis of lymphocytes from peritoneal cavity (PEC, top two rows) and lymph nodes (LN, bottom two rows).
(D) Comparison of B cell numbers from the spleen of B1-8f/JHT (white bars), CD21-cre; B1-8f/JHT mice (gray bars) and P110*/+; CD21-cre; B1-8f/JHT mice (filled
bars), mean and SD of a minimum of 6 mice per genotype.Cell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc. 575
Figure 2. P110*-Rescued IgMneg B Cells Are Arranged in Follicles in the Spleen and Are Similar to IgMpos B Cells
(A) Hematoxylin and Eosin staining of sections of spleen from a wild-type C57Bl/6 (B6) and P110*/+; CD21-cre; B1-8f/JHT (PI3K, Fetal liver chimera) mice.
(B) Immunofluorescent staining of sections of spleen showing part of a single follicle from B1-8f/JHT and P110*/+; CD21-cre; B1-8f/JHT mice. B220, marking all
B cells is stained in green, IgM is in red and MOMA1, marking metallophilic macrophages is in blue.
(C) Comparison of cell size (FSC), and surface expression of B cell markers B220, CD19, CD23 and CD21 between IgMpos (gray) and IgMneg (black) follicular
B cells from spleen of CD21-cre; B1-8f/JHT (top row) and P110*/+; CD21-cre; B1-8f/JHT (bottom row) mice.576 Cell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc.
in the population of IgMpos B cells in the CD21-cre; B1-8f/JHT
mutant chimeras (Figure 3C). Apparently, many of these cells
escaped Cre-mediated recombination by an unknown mecha-
nism.
As the P110*-rescued BCRneg cells are well controlled in terms
of overall cell numbers, one would predict that they retain the
dependence of normal mature B cells on the survival factor
BAFF. On the other hand, BAFF:BAFF-R induced activation of
the alternative NF-kB pathway leads to the phosphorylation of
Akt, which is a main downstream target of PI3K (Patke et al.,
2006; Otipoby et al., 2008). We therefore assayed the BAFF
dependence of P110*-rescued BCRneg B cells in cell culture
experiments (Batten et al., 2000; Gross et al., 2001) and found
that the survival of P110*-rescued and control cells was equally
dependent on BAFF (Figure 3D).
The P110*-rescued BCRneg B cells are thus resting, long-lived
cells, living in their normal habitats in the peripheral immune
system and subject to normal homeostatic control.
Figure 3. P110*-Rescued IgMneg B Cells Are
Resting B Cells Dependent on BAFF for
Survival
(A) Comparison of surface expression of activation
markers on IgMpos (gray histograms) and IgMneg
(black histograms) mature follicular B cells (gated
on B220+, AA4.1- and CD23 high) from the spleen
of CD21-cre; B1-8f/JHT (left column) and P110*/+;
CD21-cre; B1-8f/JHT (right column) mice.
(B) Representative FACS plots showing BrdU
incorporation in B lymphocytes from spleen after
20 days of BrdU feeding of mice of indicated geno-
type. The numbers indicate the percentage of
BrdU-positive or -negative cells within the mature
B cell fraction (B220+, AA4.1-).
(C) Graphical representation of data in B. Also
shown is incorporation of Brdu in the IgMpos mature
B cells from CD21-cre; B1-8f/JHT and P110*/+;
CD21-cre; B1-8f/JHT fetal liver chimeric mice.
(D) P110*-rescued IgMneg B cells are dependent
on BAFF for survival in vitro. IgMpos and IgMneg
mature follicular B cells from B1-8f/JHT (B1-8f),
CD21-cre; B1-8f/JHT (B1-8cre) and P110*/+;
CD21-cre; B1-8f/JHT (P110*) mice were cultured
in vitro in the presence (filled markers) or absence
(open markers) of BAFF. Data are plotted as
percent recovery of viable cells.
Failure of Canonical NF-kB
Signaling and Constitutive MEK1
and Rac1 to Efficiently Rescue
BCR-Negative B Cells
The efficient rescue of BCRneg B cells by
P110* contrasted with our failure to
rescue such cells by activation of the
canonical NF-kB pathway. We used for
this purpose the conditional IKK2ca allele,
from which constitutively active IkB
kinase 2 (IKK2) is expressed, activating
the canonical NF-kB pathway and
rescuing B cells from BAFF dependency
(Sasaki et al., 2006). Compound mutant mice of the genotypes
CD21-cre; B1-8f/JHT and IKK2ca/+; CD21-cre; B1-8f/JHT devel-
oped normally, so that the analysis of the B cell compartment did
not require the generation of fetal liver chimeras. As shown in
Figure 4, IKK2ca expression led to only a very limited rescue of
BCRneg B cells in the spleen. This was also the case in other
lymphoid organs (data not shown). Essentially all IgMneg cells ex-
pressed GFP, indicating that the cells had activated the IKK2ca
transgene. The inefficient rescue of IgMneg cells by IKK2ca is
not due to inefficient Cre-mediated recombination in this system,
because 80% of mature B cells in IKK2ca/+;CD21-cre mice ex-
pressed GFP, indicative of efficient excision of the STOP cassette
in the IKK2ca allele (Figure S3).
The inefficient rescue by IKK2ca suggests that the rescue
of BCRneg B cells by P110* is not mediated by NF-kB
activation. Indeed, when we analyzed the expression of genes
of the NF-kB pathway in such cells by quantitative RT-PCR,
we saw little change in comparison to BCRpos controls or BCRnegCell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc. 577
Figure 4. Expression of Constitutively Active IKK2 Causes Limited Rescue of IgMneg B Cells
(A) Representative FACS analysis of lymphocytes from Spleens of CD21-cre; B1-8f/JHT (left column) and IKK2CA/+; CD21-cre; B1-8f/JHT mice. Numbers repre-
sent percentages of cells within the lymphocyte gate or of cells in the gate indicated in the FACS plot.
(B) Comparison of B cell numbers fromCD21-cre; B1-8f/JHT (open bars) and IKK2CA/+; CD21-cre; B1-8f/JHT (filled bars) mice showing limited rescue of IgM
neg B
cells by the IKK2CA transgene, mean and SD of four mice per genotype.
(C) Comparison of rescue of IgMneg B cells by activation of PI3K signaling (left panel) or canonical NF-kB signaling (right panel) in the spleen. Data are plotted as
percent of mature B cells (B220+, AA4.1-).cells lacking P110* (Figure S4). Only c-Rel transcripts were about
2-fold downregulated in the latter cells compared to their BCRpos
counterparts, and this downregulation was not seen in the
P110*-rescued BCRneg cells. This result is in agreement with
Matsuda et al. (2009), who reported that PI3K activity maintains
the expression of the NF-kB proteins c-Rel and RelA.
We also analyzed the ability of two additional signaling mole-
cules, which are rapidly activated upon BCR engagement, to
rescue BCRneg B cells, namely MEK1, a member of the Raf-
MEK-Erk MAP Kinase pathway, and the Rho GTPase Rac1
(Genot and Cantrell, 2000). Activation of Rac1 upon BCR engage-578 Cell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc.ment leads to rapid actin polymerization and cytoskeletal rear-
rangements, and ablation of Rac1 and 2 blocks B cell develop-
ment (Walmsley et al., 2003). Activation of the MAP Kinase
pathway and Rac1 was done with the help of newly constructed
ROSA26 alleles, from which constitutively active MEK1, MEK1DD
(Cowley et al., 1994), or dominant active Rac1, RacDA (Kobayashi
et al., 1998) are expressedupon Cre-mediated excision of a STOP
cassette. When we used these alleles in our experimental in vivo
system, they failed to rescue BCRneg B cells in the spleen, despite
their ability to increase phospho-Erk levels and PAK1 binding
activity, respectively, in splenic B cells (Figure S5; Bokoch, 2003).
Rescue of BCRneg B Cells by Pten Knockout
To corroborate that PI3K signaling is indeed the central survival
signal in mature B cells downstream of the BCR, we assessed
whether rescue of BCRneg B cells can also be achieved by dele-
tion of the Pten tumor suppressor, the key negative regulator of
the PI3K pathway via its phosphatase directed conversion of
PIP3 to PIP2 (Suzuki et al., 2008). Pten is expressed in the B
cell lineage and known to play a role in B cell differentiation
(Anzelon et al., 2003; Suzuki et al., 2003; Omori et al., 2006).
Because Pten deletion by CD21-cre, like activation of P110*,
produces lethality in the compound mutant mice (data not
shown), chimeric mice were generated, whose lymphocytes
had either the CD21-cre; B1-8f/JHT or Ptenf/D; CD21-cre;
B1-8f/JHT genotype. The analysis of these mice revealed that
Pten ablation rescued BCRneg B cells almost as efficiently as
the P110* transgene (Figure 5). Spleens from Ptenf/D; CD21-
Cre; B1-8f/JHT mice had more B cells (Figure 5A, top row),
a decreased fraction of immature B cells (middle row) and
a substantial increase in the percentage of mature IgMneg B cells
(bottom row) in comparison to controls deleting the BCR in the
absence of Pten ablation. In the bone marrow, the Pten deleted,
rescued IgMneg (B220 high) B cells constituted 17% of all
lymphocytes (Figure 5B). Substantial fractions of rescued
BCRneg B cells were also found in lymph nodes (Figure 5C),
and peritoneal cavity (Figure 5D). As in the case of P110*, there
was no upregulation of the activation markers CD69 and MHC
II in the rescued cells (Figure 5E). They were also again identical
to their IgMpos counterparts in forward scatter analysis and ex-
pressed similar levels of the B cell markers B220, CD19, and
CD21, whereas CD23 was downregulated about 2-fold
(Figure S6). No Pten protein was detectable in the rescued cells
by western blot (Figure 5F). Histological analysis of the spleens of
the compound mutants revealed a normal organization of B cells
into follicles and MZ B cells, with the majority of the cells being
negative for IgM (Figure 5G).
The PI3K-FOXO Pathway Mediates Survival
of BCRneg B Cells
The negative regulation of FOXO transcription factors through
the serine/threonine kinase Akt, a key target of PI3K signaling,
has recently emerged as a central regulator of B cell develop-
ment and differentiation (Herzog et al., 2009; Chen et al., 2006;
Yusuf et al., 2004). Analyzing in vivo generated BCRneg B cells
in the absence of any rescue, we indeed found upregulation of
transcripts of the pro-apoptotic FOXO target genes BCL2L11
(encoding the Bcl2 family member Bim) and p27/Kip1 (Dansen
and Burgering, 2008; Figure 6), and of two additional recently
identified direct or indirect FOXO target genes, AICDA (encoding
activation induced cytidine deaminase (AID)) and recombination
activating gene 1 (RAG1; Amin and Schlissel, 2008; Dengler
et al., 2008; Herzog et al., 2008; Figure 6). In all four cases, upre-
gulation was reversed upon P110* rescue. These results are
consistent with a role for FOXO in the control of BCR-mediated
B cell survival and also indicate that P110* is active in the
rescued cells, by controlling gene expression through FOXO
transcription factors.
In the light of these results, we sought to provide direct genetic
evidence for a role for FOXO in the rescue of BCRneg B cells.While FOXO transcription factors are encoded by four different
genes (FOXO 1, FOXO 3, FOXO 4 and FOXO 6), at least two of
which (FOXO 1 and FOXO 3) are expressed in B cells (Kerdiles
et al., 2009), recent experiments indicate that FOXO1 is the
dominant player in B cell differentiation (Amin and Schlissel,
2008; Dengler et al., 2008; Herzog et al., 2008). We therefore
used a conditional FOXO1 allele (Paik et al., 2007) to delete
FOXO1 in mature B cells concomitantly with the BCR through
the CD21-cre transgene. As can be seen in Figure 7A, FOXO1
deletion in mature B cells in Foxo1f/D; CD21-cre; B1-8f/JHT
mice led to a striking accumulation of IgMneg B cells in the
spleen, with most of the cells displaying a mature (AA4.1-)
phenotype. Indeed, in these mice 90% of the mature splenic B
cells were IgMneg, with a strong reduction of the fraction of imma-
ture (AA4.1-) cells compared to controls. Efficient rescue of
BCRneg B cells was also seen in bone marrow and peritoneal
cavity (Figure S7). Comparison of B cell numbers upon rescue
by Pten or FOXO1 revealed that while in the case of Pten a larger
fraction of IgMpos cells persisted in the mice, the numbers of
rescued IgMneg cells were almost equivalent in the two mutants
(Figure 7B).
However, the BCRneg B cells rescued by FOXO1 deletion
lacked a number of properties of normal B cells, quite distinct
from what we had observed in the case of P110* and Pten. Histo-
logical analysis of the spleen from Foxo1f/D; CD21-Cre; B1-8f/
JHT revealed the efficient rescue of such cells in the follicles,
but lack of MZ B cells (Figure 7C), which was also confirmed
by flow cytometric analysis (Figure S8A). Furthermore, only
a minor fraction of BCRneg B cells was detected in lymph nodes
(Figure 7D). This correlated with a strong decrease of L-selectin
(CD62L) expression on the surface of these cells (Figure 7E).
CD62L controls the migration of lymphocytes into lymph nodes,
and in T cells FOXO1 indeed controls this process as well
as CD62L expression (Kerdiles et al., 2009). In addition, the
rescued FOXO1 deficient cells had drastically reduced levels
of CD23 on their surface, and were slightly smaller than normal
B cells or BCRneg B cells rescued by Pten knockout or P110*
(Figure S8B).
We gained some understanding of the abnormal properties of
the rescued FOXO1 knockout cells when we analyzed FOXO1
protein levels in these cells and BCRneg B cells rescued by
P110* expression or Pten knockout. While FOXO1 was undetect-
able in the former cells (Figure S9A), in the cells rescued by P110*
expression or Pten knockout FOXO1 levels were reduced to
a level roughly equivalent to that in heterozygous FOXO1 knock-
outs, correlating with a slight downregulation of CD62L on the
surface of the rescued cells, which was equally seen in BCRneg
B cells rescued by P110* (Figure 7E). This indicated that the
PI3K pathway indeed controls FOXO1 levels in mature B cells
and suggested that small changes of the concentration of FOXO1
in the cells have major effects on their physiology. Indeed, when
we analyzed the rescue of BCRneg B cells in a situation where the
BCR was conditionally deleted in mature B cells on a FOXO1+/
background, we found a 2- to 4-fold increase of BCRneg B cells in
both lymph nodes and spleen, compared to FOXO+/+ controls
(Figure S9B).
While these results indicate that the control of FOXO1 by PI3K
signaling is a central element of the BCR controlled B cell survivalCell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc. 579
Figure 5. Deletion of Pten Rescues BCRneg B Cells
Representative FACS analysis of lymphocytes from spleen (A), bone marrow (B), inguinal lymph node (iLN [C]) and peritoneal cavity (PEC [D]) from CD21-cre; B1-
8f/JHT and PtenD/f; CD21-cre; B1-8f/JHT mice showing rescue of IgM
neg mature B cells by Pten deletion. Numbers represent percentages of cells within the
lymphocyte gate or of cells in the gate as indicated in the FACS plot. (E) IgMneg cells rescued by Pten deletion are not activated. Comparison of surface expression
of activation markers CD69 and MHC class II on IgMpos (gray histograms) and IgMneg (black histograms) cells from the spleen ofCD21-cre; B1-8f/JHT andPtenD/f;
CD21-cre; B1-8f/JHT mice. (F) Western blot analysis for Pten (top panel) and Actin (bottom panel) in sorted IgM
pos and IgMneg mature B cells from spleen of
PtenD/f; CD21-cre; B1-8f/JHT mice. (G) Immunofluorescent staining of sections of spleen showing a single follicle from PtenD/f; CD21-cre; B1-8f/JHT mice.
B220, marking all B cells is stained in green, IgM is in red and MOMA1, marking metallophilic macrophages is in blue.580 Cell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc.
signal, they also reveal the subtlety of this control mechanism,
which seems to require the modulation of this transcription factor
within a narrow range.
Loss of PI3K-Mediated Akt Phosphorylation upon
BCR Ablation and Its Reconstitution
by P110* or Deletion of Pten
Sufficient BCRneg cells could be isolated from FOXO1f/D;
CD21-cre;B1-8f/JHT mice to allow biochemical analysis. We
focused on the activation of Akt through phosphorylation of
serine 473, which is known to be under PI3K control. Accord-
ingly, Akt S473 phosphorylation, detectable in resting and,
more strongly, in activated mature B cells, was abolished by
treatment of the cells with the PI3K inhibitor Ly294002 (Deane
and Fruman, 2004; Figure 7F, lanes 1–4). In BCRneg B cells
rescued by partial or complete FOXO1 ablation, Akt phosphory-
lation on S473 was strongly reduced and indeed undetectable in
2/3 experiments (Figure 7F, lanes 10–12; Figure S10A). The data
in Figure 7 and Figure S10A (repeat experiments) also show that
the extent of Akt S473 phosphorylation induced in the cells upon
rescue by P110* or Pten ablation is moderate and closer to that
seen in resting mature B cells than B cells activated by BCR
engagement or even just exposed to serum containing culture
medium. We also did not see significantly increased phosphory-
lation of the Akt targets GSK3a and b in the rescued cells (Figur-
e S10B). Finally, control and rescued cells did not exhibit any
detectable phosphorylation of the mTOR target S6 kinase
(S6K), which is strongly induced through this branch of the
PI3K pathway upon B cell activation (Engelman et al., 2006;
Figure S10C). We conclude that BCR expression mediates the
Figure 6. P110*-Rescued IgMneg Cells Do
Not Upregulate FOXO Targets
Quantitative RT-PCR analysis of FOXO targets in
sorted IgMpos and IgMneg mature B cells from
spleens of CD21-cre; B1-8f/JHT and P110*/+;
CD21-cre; B1-8f/JHT mice. Transcripts shown
include BCL2L11 (A), P27/KIP1 (B), AICDA (C),
and Rag1 (D). Lanes as indicated in the figure,
mean and SD of triplicate experiment are shown.
moderate PI3K activity seen in mature B
cells, and that, in the light of the genetic
rescue experiments, this activity is critical
for the survival of the cells.
DISCUSSION
Using concomitant BCR deletion and
activation of candidate signaling path-
ways in mature B cells in vivo, we provide
evidence that the PI3K signaling pathway
is the critical survival determinant in
mature, resting B cells downstream of
the BCR. The central evidence for this
conclusion is the efficient rescue of
mature B cells losing their BCR by either
transgenic expression of constitutively
active PI3K or knockout of the inhibitor of PI3K signaling, Pten.
In both cases, the rescue involves, as determined through the
phosphorylation of the PI3K target Akt and further downstream
components of the pathway, reconstitution of PI3K activity to
levels only modestly above those in resting BCRpos B cells,
and much below PI3K activity induced by B cell activation. Our
results also indicate that in resting mature B cells the PI3K-medi-
ated phosphorylation of Akt largely depends on BCR expression.
The rescued BCRneg cells resemble normal mature B cells
almost perfectly: They are resting, long-lived cells that populate
the same compartments in the peripheral immune system as
wild-type B cells, with B2 and MZ B cells located in their respec-
tive habitats in spleen and LNs. (The experimental system
precludes the analysis of B1 cells, which are not generated in
B1-8f mice; Lam and Rajewsky, 1999). In both B cell follicles
and the MZ, the BCRneg cells intermix with B cells that have
escaped BCR ablation, emphasizing their physiologically normal
behavior. The cells also resemble normal mature B cells in terms
of surface marker expression, with a few exceptions discussed
below. The rescued BCRneg cells comprise 60%–90% of the
total peripheral B cells, whose overall number is similar to that
seen in wild-type mice, with the exception of a slightly increased
MZ B cell compartment. This indicates that the rescued cells are
subject to the same numerical control as wild-type B cells.
Indeed, the BCRneg cells are as dependent on BAFF-BAFF-R
interactions as wild-type B cells.
The equal rescue of BCRneg B cells by constitutively active
PI3K and Pten knockout implies that mature B cells display
some PI3K activity irrespective of whether they express a BCR
or not. Modulation of PI3K signaling thus appears to be the keyCell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc. 581
Figure 7. Survival of Resting B Cells through BCR Is Mediated by PI3K-FOXO Pathway
(A) FACS analysis of lymphocytes from spleens of B1-8f/JHT (left column), CD21-cre; B1-8f/JHT (middle column) and Foxo1D/f; CD21-cre; B1-8f/JHT mice (right
column) showing rescue of IgMneg mature B cells by deletion of Foxo1.
(B) Comparison of splenic B cell numbers of the mice as indicated in the figure, mean and SD of a minimum of 4 mice per genotype are shown.
(C) Immunofluorescent staining of splenic sections from Foxo1D/f; CD21-cre; B1-8f/JHT mice.582 Cell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc.
element in the control of mature B cell survival by the BCR. This
notion is in accord with the general view that the quantitative
control of the PI3K pathway determines its manifold roles in
cellular physiology. Thus, heterozygous Pten knockout mice,
which exhibit a 50% reduction in Pten protein levels in T cells
(Di Cristofano et al., 1999; Xiao et al., 2008), develop autoimmu-
nity, and T cells from these mice have a reduced response to
Fas ligation. Monoallelic loss of Pten also contributes to tumor
growth in the context of other somatic mutations, with Pten
protein levels correlating with disease severity (Salmena et al.,
2008). Along the same lines, the graded expression of FOXO
transcription factors, which are targets of PI3K signaling, deter-
mines the balance between the proliferation and differentiation
of B cell progenitors (Amin and Schlissel, 2008; Dengler et al.,
2008; Herzog et al., 2008).
The present results demonstrate that modulation of the FOXO1
transcription factor is similarly crucial for the control of mature
B cell survival by the BCR. However, the B cells rescued by
FOXO1 ablation have a number of aberrant properties compared
to the properties of normal mature B cells and BCRneg B cells
rescued by constitutive PI3K activity or Pten knockout. There-
fore, the role of FOXO1 in the control of mature B cell survival
by BCR-mediated PI3K signaling is subtler than modeled by
our conditional loss-of-function experiment. Perhaps the FOXO
transcription factors expressed in mature B cells play redundant
and nonexclusive roles in this process.
In contrast to the efficient rescue of BCRneg cells by manipula-
tion of the PI3K signaling pathway we saw little rescue upon acti-
vation of the canonical NF-kB pathway in mature B cells losing
their BCR. The IKK2ca allele used in these experiments induces
strong canonical NF-kB signaling in mature B cells, making these
cells BAFF independent and enhancing their response to mito-
genic stimuli (Sasaki et al., 2006). The limited rescue of BCRneg
B cells by IKK2ca is in accord with our previous demonstration
that transgenic Bcl2 rescues BCRneg B cells only transiently
(Lam et al., 1997). Taken together, these results indicate that
canonical NF-kB activity, while essential for mature B cell persis-
tence under conditions of cellular competition (Pasparakis et al.,
2002), is unable to substitute for loss of the BCR in these cells
and thus does not by itself represent the critical survival signal
downstream of the BCR. This conclusion is in accord with the
presence of a large compartment of mature, resting B cells in
Bcl10 knockout mice, where BCR engagement does not elicit
canonical NF-kB activity (Ruland et al., 2001; Xue et al., 2003).
It is also supported by our findings that PI3K activation in mature
B cells did not significantly impact the transcription of NF-kB
components and target genes, except for an expected 2-fold
upregulation of c-Rel mRNA; and that FOXO1 appears to be
the major downstream target of PI3K-mediated mature B cell
survival. With respect to the work of Stadanlick et al. (2008),one might speculate that the postulated crosstalk between
BCR-mediated canonical and BAFF-R-mediated NF-kB activity
may apply to certain processes of B cell activation rather than
tonic BCR signaling in resting B cells.
While our failure to rescue BCRneg B cells by constitutively
active Rac1 was not unexpected, it is noteworthy that this was
also the case for MEK1DD, despite our demonstration that the
expression of this molecule in mature B cells in vivo mediated
substantial ERK phosphorylation. As the latter appeared to be
in the same range as ERK phosphorylation in control B cells,
this result does not support the possibility that BCR mediated
MAP kinase activation either through PI3K signaling or indepen-
dent of it (Brummer et al., 2002; Dye et al., 2007), is part of the
survival signal downstream of the BCR.
How PI3K signaling through the BCR is initiated in resting
mature B cells is not fully understood. If low affinity interactions
of the BCR with self-antigens are involved in this process, PI3K
signaling would likely be induced through the phosphorylation
of the adaptor protein BCAP and the CD19 co-receptor by
protein tyrosine kinases, with src family kinases and Syk playing
a central role (Kurosaki, 1999). It is interesting in this context that
the inactivation of a negative regulator of src family and other
kinases, c-src tyrosine kinase (Csk), in developing T cells results
in a quasi normal compartment of peripheral CD4+ T cells that
lack T cell receptor expression (Schmedt et al., 1998). In a
different model emerging from very recent evidence (Delgado
et al., 2009), the antigen receptors in resting T and B cells are
connected to the PI3K pathway by the GTPase TC21 and
perhaps other members of the family, which directly recruits
the catalytic subunit of PI3K to the non-phosphorylated immuno-
tyrosine activation motifs (ITAMs) of these receptors. In this
scenario, the ‘‘tonic,’’ PI3K-mediated survival signal is indepen-
dent of BCR engagement by an external ligand.
While the present data indicate a critical role of PI3K signaling
in BCR-mediated mature B cell survival, they clearly do not
define the survival signal in all its complexity. The slight alter-
ations in CD23 and CD62L expression in the cells rescued by
P110* or Pten ablation likely reflect the reduced FOXO1 levels
in these cells, due to the modestly increased PI3K activity in
the rescued, BCRneg compared to BCRpos control cells.
However, PI3K likely signals B cell survival through additional
targets, and we also cannot exclude minor contributions of other
signaling pathways to this process. Additional candidate PI3K
targets include the regulators of cell size and metabolism,
mTOR (Edinger and Thompson, 2002), in line with the failure of
FOXO1 deletion to rescue BCRneg cell size.
Perhaps the biggest surprise in the present study was the
finding that despite the ability of the BCR to activate a variety
of different signaling pathways in parallel (Kurosaki, 1999),
a single one of them seems to signal cellular survival.(D) FACS analysis of lymphocytes from lymph nodes of the mice as indicated in the figure showing limited rescue of IgMneg B cells in the lymph node upon deletion
of Foxo1.
(E) Comparison of surface expression of CD62L on IgMpos (gray histogram) and IgMneg (black histogram) B cells from the lymph nodes of mice as indicated in the
figure.
(F) Western blot analysis of sorted IgMpos and IgMneg B cells from mice as indicated in the figure (Lanes 5–12) for Phospho- Akt (Ser473, Top panel), Akt (middle
panel) and Actin (bottom panel). Lanes 1–4 represents mature B cells sorted fromB1-8f/JHTmice and contains two fold less protein than lanes 5–12. For a detailed
description of this experiment, see the Experimental Procedures section.Cell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc. 583
Furthermore, it is through modulation of the activity of the PI3K
pathway, a pathway that is of central importance for the homeo-
stasis and survival of higher cells in general (Engelman et al.,
2006), that BCR deficient mature B cells can be rescued. While
a contribution of an ER stress response upon loss of BCR
expression remains a possibility, our results consistently support
the concept that the survival of mature B cells depends upon
BCR-mediated activation of the PI3K pathway. We have shown
in a separate study that BCR-mediated PI3K activation also
controls the proliferative response of mature B cells to mitogens
through Toll like receptors (Otipoby, Waisman et al., unpub-
lished). We speculate that the BCR has subverted the PI3K
signaling pathway in order to integrate the control of cellular
survival and responsiveness to pathogens through innate and
cognate immune receptors. The exact mechanism of this subver-
sion remains to be elucidated. It will also be interesting to inves-
tigate, to which extent PI3K signaling controls the maintenance of
B cell lymphomas, which in the human mostly derive from mature
B cells and seem to often depend on BCR expression.
EXPERIMENTAL PROCEDURES
Genetically Modified Mice
To generate tissue-specific P110*-transgenic mice we cloned a loxP-flanked
neoR-stop cassette into a modified version of pROSA26-1. We then added
a cDNA encoding P110*, a frt-flanked IRES-eGFP cassette and a bovine poly-
adenylation sequence (R26StopFLP110*). B6 ES cells (Artemis) were trans-
fected, cultured, and selected as previously described for Bruce 4 ES cells
(Sasaki et al., 2006). Pten conditional knockout mice were purchased from
the Jackson Laboratory (stock number 006068). Other mouse strains used in
this study include Cd21-cre (Kraus et al., 2004), B1-8f (Lam et al., 1997), JHT
(Gu et al., 1993) and Foxo1f (Paik et al., 2007). Mice were analyzed at the
age of 8–12 weeks. Fetal liver chimeras were generated by transferring fetal
liver cells from 14.5 DPC embryos into sub-lethally irradiated (600rads)
Rag2/common gamma chain knockout mice purchased from Taconic farms
(stock number 004111-MM). Chimeric mice were analyzed 10–12 weeks after
transfer. All mice were bred and maintained in specific pathogen free condi-
tions. Mouse protocols were approved by the Harvard University Institutional
Animal Care and Use Committee and by the Immune Disease Institute.
Flow Cytometry
Single-cell suspensions prepared from various lymphoid organs were
stained with the following monoclonal antibodies: anti-CD19 (ID3), anti-CD23
(B3B4), anti-CD1d (1B1), anti-CD95 (Fas), anti-CD69 (H1.2F3), anti CD62L
(MEL-14), anti B220 (RA3-6B2), anti-CD93 (AA4.1), anti-MHCII (all from
eBioscience), anti-CD21 (Biolegend) and Goat anti mouse IgM (Fab fragment,
Jackson Immunoresearch). All samples were acquired either on a FACSCalibur
or FACSCanto II (BD PharMingen), and results analyzed using Flow-Jo soft-
ware (Tree star inc).
BrdU Labeling and Staining
Mice were fed with drinking water containing 0.8mg/ml BrdU (Sigma) for
20 days. Splenocytes were purified and stained using the FITC BrdU flow kit
(BD bioscience) according to manufacturers instructions.
Cell Sorting, qRT-PCR, and Immunoblotting
CD19+, AA4.1-, IgM +/ splenic mature B cells were sorted on a FACSVantage
(BD biosciences). Total RNA was isolated from the sorted cells using Trizol
(Invitrogen) and cDNA was synthesized using Superscript III cDNA synthesis
kit (Invitrogen). qPCR reactions were performed on a Step One Plus real
time PCR system using SYBR Green PCR Core reagents according to manu-
facturers instructions (Applied Biosystems). Primer sequences are listed in584 Cell 139, 573–586, October 30, 2009 ª2009 Elsevier Inc.Table S1. Immunoblotting was carried out as previously described (Xiao
et al., 2008). For details, refer Supplemental Experimental Procedures.
Histology
Tissues fixed with 10% formalin (Sigma) were stained with hematoxylin and
eosin (H&E). For immunofluorescence analysis, spleens were frozen in OCT
(Sakura Finetek) in liquid nitrogen and staining was done as described previ-
ously (Oliver et al., 1999). Antibodies used for staining include FITC anti-
B220 conjugate (BD Biosciences), Alexa 488-RS3-1 (Specific for the IgMa allo-
type) and anti-Moma1.
In Vitro Cell Survival Assay
1 3 106 Mature B cells (B220+, AA4.1-) were cultured in 0.5ml B cell medium
(complete DMEM containing 10% FCS) with or without 200ng/ml recombinant
mouse BAFF (R&D systems). The FCS was previously tested for it’s potential
to induce CD69 and MHC class II expression that are sensitive markers for
B cell activation. Viable cells were determined at each time point using the
Guava -PCA96 cell counter (Guava technologies Inc).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, 10
figures, and one table and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)01115-5.
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